Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. IRIX
IRIX logo

IRIX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy IRIDEX Corp (IRIX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.050
1 Day change
-0.94%
52 Week Range
1.650
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

IRIDEX Corp (IRIX) is not a strong buy for a beginner, long-term investor at this time. While the company has a promising product portfolio and analysts maintain a Buy rating, the weak financial performance, lack of recent positive news or catalysts, and bearish technical indicators suggest that this is not an optimal entry point. The stock's recent price trend and lack of strong trading signals further support a hold recommendation.

Technical Analysis

The MACD is slightly positive, indicating a weak bullish momentum, but the RSI is neutral at 45.709, showing no clear signal. The moving averages are bearish (SMA_200 > SMA_20 > SMA_5), and the stock is trading near its pivot point of 1.044. Support levels are at 0.964 and 0.914, while resistance levels are at 1.124 and 1.174. Overall, the technical indicators suggest a bearish trend.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
3

Positive Catalysts

  • Analysts maintain a Buy rating, citing potential growth from the Cyclo G6 laser system and Pattern Scanning Laser System. Revenue increased by 15.97% YoY in Q4 2025.

Neutral/Negative Catalysts

  • Net income dropped by 77.94% YoY, EPS fell by 80%, and gross margin declined by 15.45%. No recent news or significant trading activity from hedge funds, insiders, or Congress. Lack of strong trading signals and bearish technical indicators.

Financial Performance

In Q4 2025, revenue increased by 15.97% YoY to $14.72 million. However, net income dropped significantly by 77.94% YoY to -$184,000, EPS fell by 80% to -$0.01, and gross margin declined to 37.2%, down 15.45% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Alliance Global maintains a Buy rating but recently lowered the price target from $3 to $2.75, citing a 'flattish' 2026 outlook. The company is expected to see strong revenue growth from its key product lines.

Wall Street analysts forecast IRIX stock price to rise
Analyst Rating
0
Wall Street analysts forecast IRIX stock price to rise
Buy
Hold
Sell
0
Current: 1.060
sliders
Low
0
Averages
0
High
0
0
Current: 1.060
sliders
Low
0
Averages
0
High
0
Alliance Global
Buy
downgrade
$3
AI Analysis
2026-03-27
Reason
Alliance Global
Price Target
$3
AI Analysis
2026-03-27
downgrade
Buy
Reason
Alliance Global lowered the firm's price target on Iridex to $2.75 from $3 and keeps a Buy rating on the shares. The firm views the company's Q4 report as inline. It cites Iridex's "flattish" 2026 outlook for the target trim.
Alliance Global
initiated
$3
2026-02-05
Reason
Alliance Global
Price Target
$3
2026-02-05
initiated
Reason
Alliance Global initiated coverage of Iridex with a Buy rating and $3 price target. The ophthalmic medical technology company's key growth drivers include the Cyclo G6 laser system for the treatment of glaucoma and the Pattern Scanning Laser System for medical-retina indications, notes the analyst, who expects strong revenue growth for both the G6 laser system and the PASCAL.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for IRIX
Unlock Now

People Also Watch